
    
      This is a prospective, pilot clinical study involving two study groups. Subjects meeting the
      all the inclusion criteria and none of the exclusion criteria will be enrolled in the study.
      Subjects will receive a single SUI treatment; subjects in Group 2 will receive two SUI
      Treatments.

      At the Screening Visit, and at each pre-designated study follow-up timepoint, subjects will
      be asked to complete several quality of life questionnaires related to the treated condition.
      In addition, subjects will provide a bladder voiding diary for review and data collection,
      and a pad weight test will be conducted and results collected.
    
  